Search results
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
Digital Journal· 6 days agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven mechanisms that contribute to the broad efficacy of the vaccine ...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 3 days agoWhitefort Capital highlighted the significance of the recent U.S. District Court for the District of...
15 Black Scientists That Changed Our Understanding Of The World
AfroTech via Yahoo News· 4 days agoThe work and pioneering done by Black Americans has historically gone unrecognized across many...
Genetics Played a Role in Blood Clots Linked to COVID-19 Shots
Time Magazine· 5 days agoAdenovirus-based vaccines, like the J&J and AstraZeneca shots that were later pulled from the...
Novavax Stock Just Tripled. Is It Too Late to Buy? | The Motley Fool
The Motley Fool· 6 days agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NVAX -4.30%) stock has...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 14 hours agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...
Post-pandemic problems: These stocks are still down more than 50 percent from their Covid highs
Bankrate via Yahoo Finance· 5 days agoIts shares traded as low as $3.55 in December 2022. Covid high stock price: $376.83 Current stock...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 7 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
Blocking a Fair WHO Pandemic Accord Endangers Humanity
Foreign Policy Magazine· 15 hours agoIn Liu Cixin’s science fiction novel The Dark Forest—part of the popular Three-Body Problem series...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...